Matthew Nielsen
#174,661
Most Influential Person Now
Urologist
Matthew Nielsen 's AcademicInfluence.com Rankings
Matthew Nielsen philosophy Degrees
Philosophy
#10739
World Rank
#14736
Historical Rank
Logic
#7595
World Rank
#9401
Historical Rank
Download Badge
Philosophy
Matthew Nielsen 's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biomedical Engineering Stanford University
Why Is Matthew Nielsen Influential?
(Suggest an Edit or Addition)According to Wikipedia, Matthew E. Nielsen is an American urologist oncologist and health services researcher. He is a Full professor and Chair of Urology at the UNC School of Medicine. Nielsen joined the faculty at UNC in 2009 as a urologic oncologist and health services researcher after completing medical school and residency training at Johns Hopkins.
Matthew Nielsen 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. (2010) (483)
- Bladder cancer (2020) (381)
- Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer (2017) (244)
- ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. (2014) (219)
- Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. (2007) (204)
- Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. (2010) (188)
- Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. (2015) (181)
- Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns (2010) (181)
- Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. (2010) (177)
- Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. (2007) (164)
- Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. (2010) (163)
- Sarcopenia as a predictor of complications and survival following radical cystectomy. (2014) (153)
- Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. (2010) (153)
- Exploring the burden of inpatient readmissions after major cancer surgery. (2015) (150)
- Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. (2009) (147)
- Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009. (2015) (145)
- Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. (2010) (145)
- Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care (2012) (137)
- Contemporary evaluation of the D'amico risk classification of prostate cancer. (2007) (130)
- Geriatric assessment in surgical oncology: a systematic review. (2015) (129)
- Muscle‐invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base (2014) (123)
- Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006 (2014) (118)
- Cost analysis of robotic versus open radical cystectomy for bladder cancer. (2010) (113)
- Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. (2015) (112)
- A phase II trial of neoadjuvant erlotinib in patients with muscle‐invasive bladder cancer undergoing radical cystectomy: clinical and pathological results (2010) (110)
- Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases (2007) (108)
- Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. (2012) (105)
- High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy. (2008) (104)
- Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology. (2012) (102)
- Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. (2005) (102)
- Gender Differences in Compensation, Job Satisfaction and Other Practice Patterns in Urology. (2016) (100)
- The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. (2007) (100)
- Impact of bladder cancer on health‐related quality of life (2018) (98)
- Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy. (2008) (98)
- A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? (2011) (97)
- Recent trends in the urology workforce in the United States. (2013) (91)
- Robotic-assisted laparoscopic intracorporeal urinary diversion. (2010) (88)
- Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study (2017) (84)
- Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. (1982) (83)
- Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG (2015) (82)
- Obesity and capsular incision at the time of open retropubic radical prostatectomy. (2005) (82)
- Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy: A Study of 47 Cases (2008) (81)
- Microhematuria: AUA/SUFU Guideline. (2020) (81)
- Systematic detection and repair of subclinical inguinal hernias at radical retropubic prostatectomy. (2005) (80)
- Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity (2014) (79)
- Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. (2008) (79)
- Insight on pathogenesis of varicoceles: relationship of varicocele and body mass index. (2006) (77)
- Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study (2009) (74)
- p53 expression in patients with advanced urothelial cancer of the urinary bladder (2010) (74)
- Racial difference in histologic subtype of renal cell carcinoma (2013) (71)
- Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. (2007) (67)
- Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. (2007) (65)
- A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome (2007) (65)
- AUA White Paper on Implementation of Shared Decision Making into Urological Practice (2016) (63)
- Projecting the Urology Workforce Over the Next 20 Years. (2016) (61)
- p53 predictive value for pT1-2 N0 disease at radical cystectomy. (2009) (58)
- Robotic-assisted laparoscopic intracorporeal urinary diversion (2010) (58)
- Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"? (2008) (57)
- A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice. (2019) (53)
- Nutritional predictors of complications following radical cystectomy (2015) (51)
- Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion. (2013) (51)
- Financial Toxicity among Patients with Bladder Cancer: Reasons for Delay in Care and Effect on Quality of Life (2017) (45)
- Improving couples' quality of life through a Web-based prostate cancer education intervention (2015) (45)
- Burden of Multiple Chronic Conditions among Patients with Urological Cancer (2018) (43)
- Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. (2013) (41)
- Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care. (2016) (41)
- Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review. (2017) (40)
- Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience (2021) (39)
- Percutaneous renal cryoablation. (2006) (38)
- Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. (2009) (38)
- Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. (2006) (36)
- Opioid-prescribing patterns, storage, handling, and disposal in postoperative pediatric urology patients. (2019) (35)
- Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. (2007) (35)
- Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. (2010) (34)
- Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina Health Access and Prostate Cancer Treatment Project (HCaP‐NC) (2015) (34)
- Management of bladder cancer in older patients: Position paper of a SIOG Task Force. (2020) (33)
- Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients. (2009) (33)
- Salvage or adjuvant radiation therapy: counseling patients on the benefits. (2010) (32)
- Comparison of the Harms, Advantages, and Costs Associated With Alternative Guidelines for the Evaluation of Hematuria. (2019) (31)
- Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era (2016) (31)
- Surgical advances in bladder cancer: at what cost? (2015) (30)
- Reported use of intravesical therapy for non‐muscle‐invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey (2012) (30)
- Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer (2021) (29)
- Epidemiology of Prostate and Testicular Cancer (2016) (29)
- Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. (2017) (28)
- Robotic ureteral reconstruction distal to the ureteropelvic junction: a large single institution clinical series with short-term follow up. (2014) (27)
- Urinary markers in the detection of bladder cancer: what's new? (2006) (27)
- Receipt of guideline-concordant treatment in elderly prostate cancer patients. (2014) (27)
- The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancer. (2007) (26)
- ClearCode 34 : A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma (2014) (25)
- Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer. (2019) (25)
- The Expanding Role of Advanced Practice Providers in Urologic Procedural Care. (2017) (24)
- Readability of American online patient education materials in urologic oncology: a need for simple communication. (2015) (24)
- Cost analysis of robot-assisted laparoscopic versus hand-assisted laparoscopic partial nephrectomy. (2012) (24)
- Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years. (2013) (23)
- Health‐related quality of life among non‐muscle‐invasive bladder cancer survivors: a population‐based study (2020) (23)
- Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays (2007) (21)
- Contemporary survival trends in penile cancer: Results from the National Cancer Database. (2017) (20)
- Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS). (2015) (20)
- Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection. (2007) (19)
- Aging and cancer mortality: Dynamics of change and sex differences (2012) (19)
- Single-Institution Experience with Robotic Partial Nephrectomy for Renal Masses Greater Than 4 cm. (2016) (19)
- Use of prostate‐specific antigen testing as a disease surveillance tool following radical prostatectomy (2013) (19)
- Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer (2006) (18)
- Metabolic syndrome as a predictor for postoperative complications after urologic surgery. (2014) (17)
- Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review (2019) (17)
- Extent of pelvic lymph node dissection during radical cystectomy: is bigger better? (2014) (17)
- Impact of Location of Readmission on Outcomes After Major Cancer Surgery (2017) (16)
- Economic impact of training and career decisions on urological surgery. (2014) (16)
- Totally laparoscopic creation of a novel stapled orthotopic neobladder in the porcine model. (2008) (15)
- Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance. (2018) (15)
- A Randomized Controlled Effectiveness Trial for PSA Screening Decision Support Interventions in Two Primary Care Settings (2015) (15)
- Genomic investigation of etiologic heterogeneity: methodologic challenges (2014) (15)
- Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer (2021) (14)
- Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC). (2020) (14)
- The relationship of travel distance with cystectomy access and outcomes. (2018) (14)
- Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011. (2016) (14)
- Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. (2015) (14)
- Resident involvement and experience do not affect perioperative complications following robotic prostatectomy (2015) (14)
- Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer (2018) (13)
- A comparison of US and Australian men’s values and preferences for PSA screening (2013) (12)
- The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP‐NC (2017) (12)
- Factors Related to Job Satisfaction in Urology (2016) (12)
- Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD. (2014) (12)
- Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration (2006) (12)
- Reproducibility of mammographic classifications. (1983) (11)
- Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer (2016) (11)
- The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study (2016) (10)
- Comparison of Surveillance Strategies for Low-Risk Bladder Cancer Patients (2013) (10)
- Enhancing survivorship care planning for patients with localized prostate cancer using a couple-focused web-based, mHealth program: the results of a pilot feasibility study (2020) (10)
- A national cross-sectional survey of financial toxicity among bladder cancer patients. (2020) (10)
- Gonadotropin-releasing Hormone Agonist Overuse: Urologists’ Response to Reimbursement and Characteristics Associated with Persistent Overuse (2015) (10)
- Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation. (2020) (10)
- Current status of robot-assisted radical cystectomy (2010) (9)
- External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system. (2019) (9)
- Using qualitative research to reduce readmissions and optimize perioperative cystectomy care (2019) (9)
- Advanced Practice Providers in U.S. Urology: A National Survey of Demographics and Clinical Roles (2017) (9)
- Trends in Anemia Management in Hemodialysis Patients with Cancer (2015) (9)
- Designing for impact: identifying stakeholder-driven interventions to support recovery after major cancer surgery (2018) (9)
- Robotic cystectomy and the Internet: separating fact from fiction. (2011) (8)
- Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using a Couple-Focused mHealth Symptom Self-Management Program: Protocol for a Feasibility Study (2018) (8)
- Prevention and management of complications following robot-assisted radical cystectomy: lessons learned after >250 consecutive cases (2013) (8)
- COMBINATION OF CELL CYCLE REGULATING BIO-MARKERS IMPROVES PROGNOSIS IN PATIENTS WITH ORGAN CONFINED UROTHELIAL CANCER AT RADICAL CYSTECTOMY (2008) (8)
- Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use. (2019) (8)
- Association between treatment of superficial bladder cancer and 10‐year mortality in older adults with multiple chronic conditions (2018) (8)
- Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients. (2020) (7)
- The association between patient experience and healthcare outcomes using SEER-CAHPS patient experience and outcomes among cancer survivors. (2020) (6)
- Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment. (2016) (6)
- Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults. (2020) (6)
- Provider‐based research networks and diffusion of surgical technologies among patients with early‐stage kidney cancer (2015) (6)
- Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma. (2014) (6)
- Prognostic value of CA 125 in transitional cell carcinoma of the bladder (2010) (6)
- Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle-Invasive Bladder Cancer. (2020) (6)
- Racial differences in receipt of guideline-recommended treatment in men with low-, intermediate-, and high-risk prostate cancer (CaP): A population-based study. (2010) (6)
- Consensus on target volume delineation and treatment planning strategy for the DBCG RT Recon trial (2018) (6)
- Implementation of Post-operative Standard Opioid Prescribing Schedules Reduces Opioid Prescriptions Without Change in Patient-Reported Pain Outcomes. (2020) (6)
- Patient-Reported vs. Claims-Based Measures of Health for Modeling Life Expectancy in Men with Prostate Cancer. (2020) (5)
- Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes (2019) (5)
- Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC). (2021) (5)
- 422 FUTURE SUPPLY OF UROLOGISTS: PROJECTED TO DECREASE DRAMATICALLY BETWEEN 2009-2025 (2013) (5)
- Identifying Incidence and Risk Factors for Venous Thromboembolism (VTE) among Radical Prostatectomy Patients for Prostate Cancer (2014) (5)
- Comprehensive handbook for developing a bladder cancer cystectomy database. (2013) (5)
- Simplifying Treatment and Reducing Recurrence for Patients With Early-Stage Bladder Cancer. (2018) (4)
- Implementation science theories to inform efforts for de-implementation of urologic oncology care practices resulting in overuse and misuse. (2018) (4)
- Patient Participation in Communication about Treatment Decision-Making for Localized Prostate Cancer during Consultation Visits (2015) (4)
- Nutritional predictors for complicatons following radical cystectomy: an analysis of the American College Of Surgeons National Quality Improvement Program (ACS-NSQIP) (2013) (4)
- Opioid Stewardship in Urology: Quality Improvement Summit 2018 (2020) (4)
- Uncertainty, post-traumatic stress, and quality of life in non-muscle-invasive bladder cancer survivors. (2017) (4)
- Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Median 3-year follow-up. (2012) (4)
- Postoperative Opioid Prescribing In Urology: Are We Contributing To The National Crisis? (2018) (4)
- Use and misuse of imaging by urologists. (2010) (3)
- Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment. (2020) (3)
- Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors (2022) (3)
- The association of metformin use with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study (2018) (3)
- PROSPECTIVE RANDOMIZED TRIAL OF OPEN VERSUS ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY FOR BLADDER CANCER: INTERIM RESULTS (2009) (3)
- 1023: Inguinal Hernia Repair at the Time of Radical Retropubic Prostatectomy (2005) (3)
- Perceptions regarding prostate cancer (CaP) treatment options: Results from the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS). (2013) (3)
- 744: Cancer Control Following Radical Prostatectomy in Men with Capsular Incision (2007) (3)
- How bad are positive margins after radical prostatectomy and how are they best managed? (2009) (3)
- Use of meta-analysis of clear cell renal cell carcinoma gene expression to define a variant subgroup and identify gender influences on tumor biology. (2012) (3)
- ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY FOR BLADDER CANCER: PERI-OPERATIVE OUTCOMES IN 85 PATIENTS AND COMPARISON TO AN OPEN COHORT (2009) (3)
- The cost impact of routine addition of urovysion FISH early postoperative to non-muscle-invasive bladder cancer surveillance (2012) (2)
- Post-traumatic stress disorder symptoms in non-muscle-invasive bladder cancer survivors: A population-based study. (2020) (2)
- American Urological Association, American College of Emergency Physicians and American College of Radiology Quality Improvement Summit 2017: Challenges and Opportunities for Stewardship of Urological Imaging (2019) (2)
- Receipt of guideline-concordant treatment in elderly African American and Caucasian patients with prostate cancer. (2012) (2)
- 82 COST ANALYSIS OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY VERSUS OPEN RADICAL CYSTECTOMY UTILIZING A PROSPECTIVE, RANDOMIZED COHORT (2011) (2)
- 587: The Oncological Efficacy of Laparoscopic Retroperitoneal Lymph Node Dissection in the Treatment of Clinical Stage I Nonseminomatous Germ Cell Testis Cancer (2006) (2)
- Age, gender, and the urology work force: Evolving trends (2013) (2)
- 13 OUTCOMES OF PATIENTS WITH CLINICAL T1 GRADE 3 BLADDER UROTHELIAL CELL CARCINOMA TREATED WITH RADICAL CYSTECTOMY (2007) (2)
- Feminization of the workforce in urologic oncology: Socioeconomic, workforce, and quality-of-life issues. (2015) (2)
- 1758 PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF ROBOTIC VERSUS OPEN RADICAL CYSTECTOMY FOR BLADDER CANCER: MEDIAN 3-YEAR FOLLOW-UP RESULTS (2012) (2)
- Machine Learning Methods to Identify Missed Cases of Bladder Cancer in Population-Based Registries (2021) (2)
- Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System. (2017) (2)
- High pressure surgery. (2006) (2)
- 1231: Delay in Radical Cystectomy Over 12 Weeks is Not Associated with Adverse Outcome: Results from the Bladder Cancer Research Consortium (2006) (2)
- Natural History of Pathologically Organ-Confined (pT2), Gleason ≤ 6 Prostate Cancer Following Radical Prostatectomy (2008) (2)
- Use of meta-analysis of clear cell renal cell carcinoma gene expression to define a variant subgroup and identify gender influences on tumor biology. (2012) (2)
- The Role of Complexed Prostate-Specific Antigen in Prostate Cancer Screening (2008) (1)
- Testing the efficacy of a couple-focused, tailored eHealth intervention for symptom self-management among men with prostate cancer and their partners: the study protocol (2021) (1)
- Management and evaluation of bladder paragangliomas (2021) (1)
- AN ANALYSIS OF THE IMPACT OF RACE ON BLADDER CANCER TREATMENT AND MORTALITY (2009) (1)
- MP24-04 DIAGNOSTIC TEST PERFORMANCE OF ULTRASOUND AND CYTOLOGY IN UPPER TRACT CANCER– RESULTS FROM THE IDENTIFY STUDY (2020) (1)
- Gender disparities in chemotherapy use and survival in patients with metastatic bladder cancer (BCa). (2015) (1)
- Rebuttal from authors re: Peter Albers. Quality criteria of laparoscopic nephroureterectomy. Eur Urol. 2007;51:1481-2. (2007) (1)
- MP80-11 POST-OPERATIVE OPIOID PRESCRIBING IN UROLOGY: ARE WE CONTRIBUTING TO THE NATIONAL CRISIS? (2018) (1)
- Management of small renal masses in patients with chronic kidney disease: Perspectives from a nephrologist. (2019) (1)
- Longer Operative Times Predict Increased Length of Stay after Cystectomy (2014) (1)
- PATIENT REFUSAL OF NEO‐ADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER: PD06‐10 (2017) (1)
- Track Program in Patients Undergoing Radical ystectomy : Results in 362 Consecutive Patients (1)
- Characteristics of Physicians and Other Providers Frequently Ordering Intravenous Pyelograms. (2019) (1)
- 1779 SURVEILLANCE GUIDELINES FOR LOW GRADE NON-INVASIVE BLADDER CANCER: A COST COMPARISON (2012) (1)
- 1230: Evidence Based Gender Related Outcomes after Radical Cystectomy (2006) (1)
- OUTCOMES AND IMPLICATIONS OF FOLLOW-UP BIOPSIES OF MEN ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER (2009) (1)
- PD25-04 A COMPARISON OF EVALUATION STRATEGIES IN PATIENTS WITH ASYMPTOMATIC MICROSCOPIC HEMATURIA (2016) (1)
- Evaluating Postoperative Opioid Use after Radical Cystectomy (2018) (1)
- Cost analysis of robotic-assisted radical cystectomy versus open radical cystectomy utilizing a prospective, randomized cohort (2012) (1)
- Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Median 3-year follow-up results (2012) (1)
- PATHOLOGIC UPSTAGING AT THE TIME OF RADICAL CYSTECTOMY IS ASSOCIATED WITH WORSE RECURRENCE FREE SURVIVAL IN PATIENTS WITH BCG-REFRACTORY BLADDER CANCER (2009) (1)
- Operative Times as a Predictor of Length of Stay after Nephrectomy (2014) (1)
- Place of readmission and outcomes after major cancer surgery. (2014) (1)
- The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer (2018) (1)
- Risk-specific intensity of surveillance practices in non-muscle-invasive bladder cancer: Results from the BCAN/SUO/AUA/LUGPA electronic survey. (2011) (1)
- Percutaneous image-guided urologic procedures. (2006) (1)
- Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer. (2019) (1)
- Surveillance guidelines for low grade non-invasive bladder cancer: A cost comparison (2012) (1)
- Carcinoma in a cadaveric transplant kidney. (2012) (1)
- Impact of Surgeon Age on Preference for Open vs Robotic Radical Prostatectomy (2018) (1)
- MP2-15 IDENTIFYING INCIDENCE AND RISK FACTORS FOR VTE AMONG CYSTECTOMY PATIENTS FOR BLADDER CANCER (2014) (1)
- Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle‐invasive bladder cancer in a multisite, community‐based cohort (2020) (1)
- A validated 34-gene signature for assessing risk of recurrence in clear cell renal cell carcinoma. (2013) (1)
- Impact of Surgeon Age on Preference for Open vs Laparoscopic/Robotic Partial and Radical Nephrectomy: Potential Implications of an Aging Workforce (2018) (1)
- 384: Prognostic Significance of Gleason Grade Discrepancies between Needle Biopsy and Radical Prostatectomy (2007) (1)
- Predictors of quality of life in non-muscle-invasive bladder cancer survivors. (2017) (1)
- Reported patterns of utilization of intravesical therapy in non-muscle-invasive bladder cancer: Results from the BCAN/SUO/AUA/LUGPA electronic survey. (2011) (1)
- Time-to-Treatment after Cancer Diagnosis and the Patient Experience with Care: A SEER-CAHPS Study (2020) (1)
- Robotic radical cystectomy: Medium-term oncologic follow-up. (2011) (1)
- PD17-07 PROJECTING THE UROLOGY WORKFORCE OVER THE NEXT 20 YEARS (2016) (1)
- Surgical Equipment Cost Awareness among Urological Surgeons (2016) (1)
- The legacy of Ernest A. Codman in the 21st century. (2014) (1)
- Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival? (2008) (1)
- Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder Cancer in older adults: A population-based analysis. (2021) (0)
- 927 ROBOTIC-ASSISTED LAPAROSCOPIC INTRACORPOREAL URINARY DIVERSION: COMBINED INITIAL EXPERIENCE (2011) (0)
- PD38-11 DOES A SEPARATE DEEP MARGIN PATHOLOGY SPECIMEN DURING TRANSURETHRAL RESECTION OF BLADDER TUMOR INCREASE THE RATE OF MUSCULARIS PROPRIA FOUND ON PATHOLOGY? A RESIDENT-DRIVEN QUALITY IMPROVEMENT INITIATIVE (2021) (0)
- MP51-17 IMPACT OF SURGEON PRACTICE LOCATION AND EMPLOYMENT TYPE ON PROCEDURAL PRACTICE PATTERNS: POTENTIAL IMPLICATIONS OF A DECLINING NON-METROPOLITAN (NM) WORKFORCE (2018) (0)
- Effectiveness of chemotherapy administration and time to cystectomy following neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in the academic and community settings. (2015) (0)
- PD41-07 EVALUATING THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING NEPHRECTOMY (2016) (0)
- MP63-07 THE ASSOCIATION BETWEEN PREOPERATIVE LEUKOCYTOSIS AND POSTOPERATIVE OUTCOMES FOLLOWING CYSTECTOMY FOR BLADDER CANCER (2016) (0)
- 1746 AN EVALUATION OF NEOADJUVANT CHEMOTHERAPY ELIGIBILITY RATES AMONG PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER (2012) (0)
- Designing for Impact: Multidisciplinary Program to Identify Novel Interventions in Support of Recovery After Major Cancer Surgery (2017) (0)
- Editorial comment. (2012) (0)
- FINANCIAL TOXICITY PREVALENCE AND DELAY IN CARE AMONG BLADDER CANCER PATIENTS: MP04‐01 (2017) (0)
- Advanced Practice Providers in US Urology (2016) (0)
- Re: Association of Hospital Participation in a Quality Reporting Program with Surgical Outcomes and Expenditures for Medicare Beneficiaries (2015) (0)
- Place matters: Identifying communities with unequal risk for prostate cancer. (2015) (0)
- 392: Novel Risk Classification Model for Recurrencefollowing Radical Prostatectomy (RP) (2007) (0)
- 613: Natural History of Organ-Confined, Gleason ≤6 Prostate Cancer Following Radical Prostatectomy (RP) (2007) (0)
- Ability of clinicians to estimate stage and grade of bladder cancer on cystoscopy: Results from the IDENTIFY study (2020) (0)
- PD17-08 THE ASSOCIATION OF TRAVEL DISTANCE TO CYSTECTOMY ON READMISSION AND SURVIVAL (2016) (0)
- Significance of re-resecting T1 bladder tumors: single-institution analysis in a modern cohort of patients (2011) (0)
- Impact of obesity as a competing risk factor in prostate cancer (2010) (0)
- REPLY (2008) (0)
- MP46-10 EVALUATING THE COST-EFFECTIVENESS OF SURVEILLANCE SCHEDULES FOR RECURRENCE IN LOW-RISK BLADDER CANCER PATIENTS (2016) (0)
- MP17-07 COSTS AND OUTCOMES ASSOCIATED WITH THE MANAGEMENT OF PATIENTS ACUTELY PRESENTING WITH NONNEUROGENIC URINARY RETENTION (2021) (0)
- The impact of a multidisciplinary approach in the management of urologic malignancies: Does it influence diagnostic and treatment decisions? (2009) (0)
- PD32-06 PATIENT REPORTED VS. CLAIMS BASED LIFE EXPECTANCY TOOLS: EXTERNAL VALIDATION OF PREDICTION MODELS IN MEN WITH PROSTATE CANCER (2020) (0)
- 1213 THE EVALUATION OF THE LEARNING CURVE ASSOCIATED WITH ROBOTIC RADICAL CYSTECTOMY: INITIAL 100 CASES (2011) (0)
- Recurrence and survival following preoperative sorafenib for advanced renal cell carcinoma. (2011) (0)
- IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- The effect of distance to a high-volume center on receipt of treatment for invasive bladder cancer. (2016) (0)
- 542 IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- Does the time of day or day of the week affect outcomes after robotic radical prostatectomy (2010) (0)
- V1881 INITIAL EXPERIENCE WITH ROBOTIC-ASSISTED APPROACHES TO PARTIAL CYSTECTOMY (2011) (0)
- Editorial Comment. (2019) (0)
- MP78-14 REDUCING DECISIONAL CONFLICT IN MEN MAKING TREATMENT DECISIONS ABOUT LOCALIZED PROSTATE CANCER (2015) (0)
- 442 REGIONALIZATION OF RADICAL CYSTECTOMY: TRENDS BY HOSPITAL VOLUME 1996–2009 USING STATE DISCHARGE DATA (2011) (0)
- MULTI-INSTITUTIONAL EVALUATION OF THE PREDICTIVE VALUE OF P53 IMMUNOHISTOCHEMICAL STAINING IN PATIENTS WITH PT1-2 N0 DISEASE AT RADICAL CYSTECTOMY (2008) (0)
- Editorial comment. (2012) (0)
- The association of malnutrition and sarcopenia with geriatric assessment impairment and outcomes in patients with bladder cancer undergoing cystectomy. (2021) (0)
- Predictors of 30-Day Readmission after Radical Cystectomy for Bladder Cancer (2014) (0)
- 1824 THE IMPACT OF RACE AND GENDER IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER (2010) (0)
- 1832 PRELIMINARY EXPERIENCE WITH PROSTATE-SPARING CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER (2010) (0)
- MP58-19 FUNCTIONAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY IN WOMEN WITH BLADDER CANCER: A SYSTEMATIC REVIEW (2015) (0)
- Does robotic radical cystectomy for bladder cancer affect long-term health-related quality of life? (2010) (0)
- PD32-02 WHAT REALLY MATTERS WHEN PREDICTING OTHER CAUSE MORTALITY FOR MEN WITH PROSTATE CANCER: A MACHINE LEARNING APPROACH TO VARIABLE SELECTION (2020) (0)
- MP24-02 GLOBAL VARIATION IN CANCER DETECTION RATES IN PATIENTS REFERRED TO SECONDARY CARE WITH HAEMATURIA: DO SOME OVER INVESTIGATE? RESULTS FROM THE IDENTIFY COLLABORATIVE STUDY (2020) (0)
- Reducing decisional conflict in men making treatment decisions on newly diagnosed localized prostate cancer. (2015) (0)
- Effect of race on survival of metastatic renal cell carcinoma treated with VEGFR-TKI therapy. (2013) (0)
- V1885 THE STEPWISE APPROACH TO ROBOTIC-ASSISTED LAPAROSCOPIC INTRACORPOREAL URINARY DIVERSION (2011) (0)
- Scrutinizing Medicare Payments to the Highest Paid Urologists Using the Centers for Medicare and Medicaid Services Public Use Dataset (2018) (0)
- Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience (2022) (0)
- Nestin in Prostate Cancer Migration and Metastasis Associated Intermediate Filament − Roles for the Stem Cell (2007) (0)
- 137 UTILIZATION OF PREOPERATIVE CHEMOTHERAPY AND ASSOCIATED OUTCOMES AFTER RADICAL CYSTECTOMY: AN ANALYSIS OF THE AMERICAN COLLEGE OF SURGEONS NATIONAL QUALITY IMPROVEMENT PROGRAM (2013) (0)
- Trends in prostatectomy: Centralization, robotics, and access to care. (2010) (0)
- GEOGRAPHIC REGION STRONGLY INFLUENCES TOTAL CHARGES PER PROSTATECTOMY IN THE HCUP-NIS 2004 DATABASE (2009) (0)
- 734 DOES OBESITY IMPACT OUTCOMES IN PATIENTS UNDERGOING ROBOTIC CYSTECTOMY FOR BLADDER CANCER: A MULTI-INSTITUTIONAL ANALYSIS (2010) (0)
- 675: Body Mass Index and Outcomes in African-American and Caucasian Men Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2005) (0)
- Elimination of bowel preparation in patients undergoing cystectomy and urinary diversion (2010) (0)
- PD2-05 PREDICTORS OF 30-DAY READMISSION FOLLOWING PARTIAL AND RADICAL NEPHRECTOMY FOR KIDNEY CANCER (2014) (0)
- Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: Median 3-year follow-up. (2012) (0)
- 1412: Impact of Delayed Intervention after Radical Prostatectomy on Cancer Control in Patients with High-Risk, Locally Advanced Adenocarcinoma of the Prostate (2007) (0)
- Diagnostic test accuracy for USS, CTU and cytology in the detection of bladder cancer: Results from the IDENTIFY study (2020) (0)
- MP5-05 UNDERSTANDING THE RELATIONSHIP BETWEEN 30— AND 90—DAY EMERGENCY ROOM VISITS AND READMISSIONS FOLLOWING RADICAL CYSTECTOMY (2015) (0)
- Editorial Comment. (2017) (0)
- Is the Geriatric Assessment a Good Tool to Predict Postoperative Outcomes in Bladder Cancer Patients Undergoing Radical Cystectomy? (2020) (0)
- Editorial Comment. (2019) (0)
- Potential underuse of repeat resection among patients with high-grade non-muscle invasive bladder cancer. (2017) (0)
- MP16-16 THE FEMINIZATION OF THE WORKFORCE IN UROLOGY: SOCIOECONOMIC, WORKFORCE, AND QUALITY OF LIFE ISSUES (2015) (0)
- Trends in the age and gender of the urology workforce in the United States: 1981-2009 (2012) (0)
- 1294 A MULTI-INSTITUTIONAL PROSPECTIVE CLINICAL TRIAL OF DELAYED INTERVENTION AND SURVEILLANCE FOR SMALL RENAL MASSES: THE DISSRM REGISTRY (2012) (0)
- Urologist Attitudes towards Risk Prediction Tools, Electronic Health Records, and Surgical Clinical Decision Support (2020) (0)
- Targetable Action Points to Enhance Surgical Decision-Making (2021) (0)
- 813 INITIAL OBSERVATIONS OF THE DISSRM (DELAYED INTERVENTION AND SURVEILLANCE FOR SMALL RENAL MASSES) REGISTRY (2010) (0)
- MP44-06 PROS VS. CLAIMS: PREDICTING LIFE EXPECTANCY FOR MEN WITH PROSTATE CANCER (2019) (0)
- Patterns of chemotherapy administration in bladder preservation therapy (BPT) for muscle-invasive bladder cancer (MIBC). (2016) (0)
- Trends in androgen-deprivation therapy use among privately insured men with prostate cancer, 2001-2010. (2014) (0)
- What to do when bacillus Calmette‐Guérin fails (2015) (0)
- Epidemiology of Prostate Cancer (2013) (0)
- PD11-02 IMPORTANCE OF PATIENT-REPORTED OUTCOMES IN IMPROVING PERIOPERATIVE CARE AMONG CYSTECTOMY PATIENTS (2018) (0)
- 938 ROBOTIC-ASSISTED LAPAROSCOPIC INTRACORPOREAL URINARY DIVERSION (2010) (0)
- 1358 LONG-TERM FOLLOW-UP OF PATIENTS INITIALLY MANGED WITH ACTIVE SURVEILANCE FOR SOLID RENAL MASSES (2010) (0)
- 1688 LONG-TERM FOLLOW-UP OF PATIENTS INITIALLY MANGED WITH ACTIVE SURVEILANCE FOR SOLID RENAL MASSES (2012) (0)
- Editorial Comment (1977) (0)
- Differences in complications and associated risk factors in open versus laparoscopic partial nephrectomy (2013) (0)
- Diagnostic utility of axial imaging in the evaluation of hematuria: A systematic review and critical appraisal of the literature. (2020) (0)
- MP38-11 EVALUATING THE PREVALENCE OF AND RELATIONSHIP BETWEEN MALNUTRITION AND SARCOPENIA IN PATIENTS WITH BLADDER CANCER UNDERGOING CYSTECTOMY (2021) (0)
- 1622 MORBIDITY AND MORTALITY FOLLOWING RADICAL CYSTECTOMY: AN ANALYSIS OF THE AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (2013) (0)
- Identifying Incidence and Risk Factors for Venous Thromboembolism among Partial and Radical Nephrectomy Patients for Kidney Cancer (2014) (0)
- Private Practice, Academics, or Employed: Does Employment Status Affect Work, Income, and Job Satisfaction? (2015) (0)
- Re : Association between Choice of Radical Prostatectomy , External Beam Radiotherapy , Brachytherapy , or Active Surveillance and Patient-Reported Quality of Life among Men with Localized Prostate Cancer (2017) (0)
- MP02-08 DISPARATE ACCESS TO ELECTRONIC HEALTH RECORDS AND QUALITY REPORTING AMONG US UROLOGISTS (2018) (0)
- 130 PRACTICE TYPE AND EMPLOYMENT OF UROLOGISTS IN THE UNITED STATES: AN ANALYSIS OF CHANGES OVER THE PAST DECADE (2012) (0)
- MP69-17 EVALUATING THE TIMING OF SURGICAL COMPLICATIONS FOLLOWING PROSTATECTOMY (2016) (0)
- 1507: Insight on the Pathogenesis of Varicoceles: Relationship of Varicocele with BMI (2005) (0)
- of Studies Examining Outcomes in Geriatric Surgical Oncology (2011) (0)
- An evaluation of adjuvant chemotherapy eligibility rates among patients undergoing radical cystectomy (2011) (0)
- MP39-07 CHARACTERISTICS OF ELECTRONIC HEALTH RECORD USE AMONG UROLOGISTS IN THE UNITED STATES (2019) (0)
- The Combination of Multiple Cell Cycle Regulators Improves Prognosis in Patients with Pathologic Organ-Confined Bladder Cancer: A Multicenter External Validation Study (2010) (0)
- 70 METABOLIC SYNDROME AS A USEFUL PREDICTOR OF COMPLICATIONS FOLLOWING GU ONCOLOGIC SURGERY (2013) (0)
- The impact of radical cystectomy on renal function: An analysis of variance based on age, gender, race and diversion technique (2010) (0)
- Erratum (2011) (0)
- 277 AN ANALYSIS OF THE SUPPLY OF UROLOGIC SURGEONS IN THE UNITED STATES (2012) (0)
- Racial differences in prostate-specific antigen in hypogonadal men treated with testosterone replacement therapy (2009) (0)
- PURPOSE RESULTS CONCLUSION Cost Analysis of Robot-Assisted Radical Cystectomy versus Open Radical Cystectomy Utilizing a Randomized Cohort (2010) (0)
- 1263: Competing Risks Nomogram Predicting the Probability of Bladder Cancer Recurrence after Cystectomy can Reliably Distinguish between those Destined to Recur and those who May Die of Other Causes before Recurrence (2006) (0)
- 379: A Critical Analysis of the Interpretation of Biochemical Recurrence in Surgically Treated Patients using the Revised ASTRO Criterion–"NADIR +2" (2007) (0)
- DIAGNOSTIC DILEMMA: MUSCULOSKELETAL MEDICINE (2006) (0)
- Cost-Utility Analysis of Cystectomy Versus Chemo-Radiation for Treatment of Muscle-Invasive Bladder Cancer in the Elderly (2014) (0)
- Defining molecular determinants of sensitivity to EGFR inhibition in urothelial carinoma. (2011) (0)
- MP19-20 RISK PREDICTION TOOLS IN AN INTUITION-BASED WORLD: A MIXED METHODS STUDY OF UROLOGIC SURGEONS (2021) (0)
- Pilot study of [18F] fluorodexoyglucose positron emission tomography-magnetic resonance imaging (FDG-PET-MRI) for staging of muscle-invasive bladder cancer. (2019) (0)
- Robotic-Assisted Laparoscopic Anterior Pelvic Exenteration for Bladder Cancer in the Female (2011) (0)
- Patterns of utilization of urine-based markers in non-muscle-invasive bladder cancer: Results from the BCAN/SUO/AUA/LUGPA electronic survey (2011) (0)
- Does laterality of positive needle biopsy in clinical T2a prostate cancer patients affect biochemical recurrence free survival? (2009) (0)
- The relationship between travel distance to cystectomy and likelihood of readmission. (2016) (0)
- THE RELATIONSHIP BETWEEN FINANCIAL TOXICITY AND QUALITY OF LIFE AMONG BLADDER CANCER PATIENTS: MP86‐05 (2017) (0)
- Pediatrie genitourinary oncology (2019) (0)
- Percutaneous, image guided urological procedures: barbarians at the gate. (2005) (0)
- LONGTERM ONCOLOGICAL EFFICACY OF LAPAROSCOPIC RADICAL NEPHRECTOMY FOR CLINICALLY LOCALISED RCC >7CM (2008) (0)
- Patient Experience and Clinical Outcomes in Urologic Cancers: A Surveillance, Epidemiology, and End Results and Consumer Assessment of Healthcare Providers and Systems Study (2019) (0)
- ANALGESIC USE IN MEN UNDERGOING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: A DETAILED ANALYSIS OF DEMOGRAPHIC, CLINICAL, AND OPERATIVE, INFLUENCES (2009) (0)
- Genitourinary trauma (2019) (0)
- 1823 THE IMPACT OF RADICAL CYSTECTOMY ON RENAL FUNCTION: AN ANALYSIS OF VARIANCE BASED ON AGE, GENDER, RACE AND DIVERSION TECHNIQUE (2010) (0)
- The Impact of a Fellowship and Career Focus in Urology on Socioeconomic, Workforce, and Quality of Life Issues (2015) (0)
- Robotic-assisted laparoscopic radical prostatectomy: evaluation of the functional and oncologic learning curve (2010) (0)
- THE AFFECT OF AGE ON THE LONG-TERM EMOTIONAL AND PHYSICAL WELL-BEING OF PATIENTS UNDERGOING RADICAL CYSTECTOMY. (1998) (0)
- Global variation in cancer detection rates in patients referred to secondary care with haematuria: Do some over investigate? Results from the IDENTIFY collaborative study (2020) (0)
- Does the time of year affect outcomes after robotic-assisted laparoscopic radical prostatectomy? (2010) (0)
- MP16-12 INTEGRATED GENE EXPRESSION PROFILING AND TARGETED PANEL SEQUENCING TO IMPROVE TREATMENT SELECTION IN NON-MUSCLE INVASIVE BLADDER CANCER (2021) (0)
- Understanding the Relationship Between 30- and 90-Day Emergency Room Visits, Readmissions, and Complications after Radical Cystectomy (2015) (0)
- 445 META-ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA GENE EXPRESSION DELINEATES SUBGROUPS (2012) (0)
- ANALGESIC USE IN OPEN VERSUS ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (2009) (0)
- Editorial comment. (2010) (0)
- Editorial comment. (2012) (0)
- Understanding the Trajectory of Functional Status and Symptoms in the 90-Day Cystectomy Period (2016) (0)
- Establishing a Population-Based Cohort of Nonmuscle Invasive Bladder Cancer Cases to Improve Care by Enhancing Surveillance and Risk Stratification (2017) (0)
- Editorial comment. (2011) (0)
- 340 WHO MAKES THE DECISION REGARDING TREATMENT FOR LOCALIZED PROSTATE CANCER, PATIENT OR PHYSICIAN? RESULTS FROM A POPULATION-BASED STUDY (2012) (0)
- Initial experience with robotic ureteral surgery (2011) (0)
- 893 DEFINING THE MOLECULAR DETERMINANTS OF SENSITIVITY TO EGFR INHIBITION IN UROTHELIAL CARCINOMA (2012) (0)
- Reply to Association between treatment of superficial bladder cancer and 10‐year mortality in older adults with multiple chronic conditions (2018) (0)
- Neurourology, urodynamics, and urogynecology (2019) (0)
- 1320 PREDICTING URINE CULTURE RESULTS IN AFEBRILE PATIENTS WITH ACUTE STONE DISEASE (2010) (0)
- PD05-06 PHYSICAL THERAPY FOR ORCHALGIA (2017) (0)
- 1300 ESTIMATING THE BURDEN OF PREOPERATIVELY MISCLASSIFIED, SURGICALLY REMOVED BENIGN RENAL MASSES IN THE UNITED STATES: IMPLICATIONS FOR THE CURRENT STANDARD OF CARE (2013) (0)
- 1649 MULTI-INSTITUTIONAL ANALYSIS OF ROBOTIC RADICAL CYSTECTOMY FOR BLADDER CANCER: PERI-OPERATIVE OUTCOMES IN 227 PATIENTS (2010) (0)
- Changes in Health-Related Quality of Life Among Older Adults with Prostate Cancer: A Case-Control Study (2017) (0)
- Cost analysis of robotic-assisted laparoscopic radical cystectomy for bladder cancer (2009) (0)
- 11 ROBOTIC CYSTECTOMY AND THE INTERNET: FACT OR FICTION? (2010) (0)
- Robotic-assisted laparoscopic radical cystectomy: Evaluation of the learning curve (2008) (0)
- MP24-02 GEOGRAPHIC VARIATION OF PROSTATE CANCER INCIDENCE RATE: AN ECOLOGICAL STUDY (2015) (0)
- Complications associated with robotic radical cystectomy for bladder cancer: a multi-institutional analysis (2010) (0)
- Patterns of utilization of urine-based markers in non-muscle-invasive bladder cancer: Results from the BCAN/SUO/AUA/LUGPA electronic survey. (2011) (0)
- The evolving role and age structure of international medical graduates (IMGs) on the urology workforce in the United States: 1981-2009 (2012) (0)
- Urological Survey Urological Oncology : Adrenal , Renal , Ureteral and Retroperitoneal Tumors Re : ClearCode 34 : A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma (2014) (0)
- Changes in androgen deprivation therapy overuse: Reimbursement response and characteristics of persistent overusers. (2014) (0)
- Evaluation of the learning curve associated with robotic radical cystectomy: Initial 100 cases (2010) (0)
- The incidence of a second urologic malignancy (bladder cancer and kidney cancer) in men with a diagnosis of prostate cancer (2010) (0)
- Feasibility of Structured Telephone Calls for Symptom Management after Cystectomy (2016) (0)
- Cost‐Effectiveness of Single Versus Confirmatory Urinalysis in the Evaluation of Asymptomatic Microhematuria (2017) (0)
- Racial Disparities and the Global Picture (2013) (0)
- 443 CLEAR CELL RENAL CELL CARCINOMA DISPLAYS DIFFERENTIAL GENE EXPRESSION BASED ON GENDER (2012) (0)
- Oncologic outcomes for node-positive patients undergoing robotic radical cystectomy. (2011) (0)
- 1118: Five Year Oncological Outcome after Laparoscopic Radical Nephroureterectomy (2006) (0)
- Perioperative Care: The Radical Cystectomy Pathway (2014) (0)
This paper list is powered by the following services:
Other Resources About Matthew Nielsen
What Schools Are Affiliated With Matthew Nielsen ?
Matthew Nielsen is affiliated with the following schools:
- Université de Montréal
- University of Michigan
- North Carolina State University
- University of Kansas
- Stanford University
- Johns Hopkins University
- University of North Carolina at Chapel Hill
- University of California, San Francisco
- University of Florida College of Medicine
- University of Texas Southwestern Medical Center
